Give Kids a Chance Act of 2022

Senate Bill 4215 - Give Kids a Chance Act of 2022: Overview, Status, and Impact

Hozzl · 2024-03-13T02:40:11Z

Explore the details of Senate Bill 4215 Give Kids a Chance Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/13/2024, 2:40 AM

Congressional Summary of S 4215

Give Kids a Chance Act of 2022

This bill authorizes the Food and Drug Administration (FDA) to take various actions regarding pediatric cancer treatments, such as requiring pediatric cancer trials involving a combination of drugs when an applicant seeks market approval for a new drug (or biological product).

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 4215

Bill S 4215 is currently in the status of Bill Introduced since May 12, 2022. Bill S 4215 was introduced during Congress 117 and was introduced to the Senate on May 12, 2022. Bill S 4215's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of May 12, 2022

Bipartisan Support of Bill S 4215

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 4215

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4215

Give Kids a Chance Act of 2022

A bill to amend the Federal Food, Drug, and Cosmetic Act to establish additional authorities of the Food and Drug Administration regarding the conduct of pediatric investigations of molecularly targeted drugs to treat cancer, and for other purposes.